Diehn: Tumors at early stg assoc'd with better 5-y OS; 95% for CR Stg I vs 10% at Stg IV; for NSCLC, 60% at Stg I, 5% at Stg IV. #Tricon

12:09pm February 23rd 2017 via Hootsuite